The Lamy

At a glance

The Lamy filed 26 disclosures in the last 12 months, including 2 insider and 2 5% holder. The most recent key filing was on Sep 8.

Revenue for 2025 was ₩50.9B, down 27% on 2024. It made an operating loss of ₩1.7B. Debt was 6% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩22.9B and operating loss of ₩1.5B.

The 2025 annual report lists 45 employees with an average tenure of 1.9 years and average pay of ₩49.5M. Its 5 directors and auditors were paid ₩47.5M each on average. It paid no cash dividend for 2025. (주)바이오스마트 and related parties held 53.05% at year end.

From the 2025 annual report

Staff: 45 (11 men, 34 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.2B. Directors and auditors: 5, paid ₩237.6M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)바이오스마트 holds 28.29%; with 1 related party the group holds 53.05% of common shares at year end.

Auditor: 안진회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary